Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC augmentation in resistant OCD
NCT01555970Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Mar 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in obsessive compulsive disorder (OCD), sponsored by Universidade de São Paulo. Started Mar 2012; status: completed.
02
Drugs
acetylcysteine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01555970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555970.